This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chevalier, B. Search for Related Content PubMed Articles by Chevalier, B. Related Collections Related Article

A Randomized, Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of Zotarolimus- Versus Paclitaxel-Eluting Stents in De Novo Occlusive Lesions in Coronary Arteries

The ZoMaxx I Trial

Bernard Chevalier, MD^_*, Carlo Di Mario, MD, Franz-Josef Neumann, MD, Flavio Ribichini, MD, Philip Urban, MD^||, Jeffrey J. Popma, MD^¶, Peter J. Fitzgerald, MD, PhD^#, Donald E. Cutlip, MD^_**, David O. Williams, MD, John Ormiston, MD, Eberhard Grube, MD, Robert Whitbourn, MD^||||, Lewis B. Schwartz, MD^¶¶,_* for the ZoMaxx I Investigators

^_* Centre Cardiologique du Nord; Saint-Denis, France
Royal Brompton Hospital; London, England
Herz-Zentrum Bad Krozingen; Bad Krozingen, Germany
Università del Piemonte Orientale; Novara, Italy
^|| La Tour Hospital; Geneva, Switzerland
^¶ Brigham & Women's Hospital; Boston, Massachusetts
^# Stanford University Medical Center; Palo Alto, California
^_** Harvard Clinical Research Institute; Boston, Massachusetts
Rhode Island Hospital; Providence, Rhode Island
Auckland City Hospital; Auckland, New Zealand
Heart Center Siegburg; Siegburg, Germany
^|||| St. Vincent's Hospital; Melbourne, Australia
^¶¶ Abbott Laboratories; Abbott Park, Illinois

View larger version (112K): [in this window] [in a new window] [Download PPT slide]   Figure 1 The ZoMaxx Stent Platform Consisting of a Trilayer of Stainless Steel, Tantalum, and Stainless Steel

View larger version (21K): [in this window] [in a new window] [Download PPT slide]   Figure 2 The Molecular Structure of Zotarolimus

View larger version (14K): [in this window] [in a new window] [Download PPT slide]   Figure 3 Distribution of In-Segment Late Loss in the Taxus and ZoMaxx Cohorts of the ZoMaxx I Trial